Estrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment
New TSRI study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogensScientists from The Scripps Research Institute (TSRI) have discovered that two estrogen-mimicking…
A kiss of death for prostate cancer
Hokkaido University researchers have uncovered a cellular protein that stabilizes a tumor promoting signaling pathway, suggesting a new target to treat prostate cancer.
Cervical cancer diagnoses and deaths to rocket in older women
Incidence of cervical cancer in young women is set to decline 75 per cent by 2040 with deaths close to eradicated, however older women will face greater risk…
Active Surveillance of Low-Risk Papillary Microcarcinoma of the Thyroid Proposed as First-Line Management
A 10-year study of more than 1,200 patients with low-risk papillary microcarcinoma (PMC) of the thyroid led researchers to conclude that close and continuous monitoring is an acceptable…
Postmenopausal breast cancer: It is sufficient to extend treatment by two years
Standard treatment for postmenopausal breast cancer is to give a hormonal breast cancer drug for 5 years following surgical removal of the tumour.